Murugappa Executive and Leadership Team

Jayateerth Nadgir, the Vice President and Chief Executive Officer - Murugappa Water Technology and Solutions at Murugappa, directs all strategic initiatives regarding water purification and industrial fluid management. Overseeing the expansion of advanced filtration systems across the Indian subcontinent, the Vice President and Chief Executive Officer - Murugappa Water Technology and Solutions ensures that technical infrastructure meets the rigorous demands of modern manufacturing. This leadership role involves coordinating with engineering teams to optimize resource efficiency and sustainability protocols. By integrating cutting-edge bio-product research into water treatment workflows, Jayateerth Nadgir directly impacts the operational viability of the conglomerate. Furthermore, the Vice President and Chief Executive Officer - Murugappa Water Technology and Solutions manages cross-functional partnerships to scale these solutions globally. Through consistent focus on innovation, Nadgir secures a competitive advantage for the organization within the critical water technology sector, ensuring long-term environmental and financial performance.

Govind Malpani, the Chief Financial Officer at Murugappa, directs the fiscal strategy and capital allocation for the entire business conglomerate. Overseeing the financial health of diverse entities ranging from automotive parts to food processing, the Chief Financial Officer ensures robust liquidity and sustainable investment growth. This leadership role involves managing complex risk assessment frameworks and reporting standards to satisfy international stakeholders. By optimizing the balance sheet and driving cost-efficiency initiatives, Govind Malpani directly impacts the long-term profitability of the organization. Furthermore, the Chief Financial Officer coordinates with regional directors to support expansion efforts across emerging markets. Through meticulous oversight of budgetary controls and capital expenditure, Malpani secures the financial foundation of the group, enabling the company to pursue aggressive innovation and market penetration while maintaining a disciplined approach to fiscal management and shareholder value creation.

John Joy, the Chief of Staff at Murugappa, directs the internal alignment of corporate objectives across the diverse business units of the conglomerate. Overseeing the execution of high-level strategic projects, the Chief of Staff ensures that departmental goals remain synchronized with the overarching vision of the holding company. This leadership role involves facilitating communication between the board and various operational heads to streamline decision-making processes. By optimizing organizational workflows, John Joy directly impacts the efficiency of the group's automotive and chemical divisions. Furthermore, the Chief of Staff manages the implementation of corporate governance standards to maintain operational integrity. Through rigorous oversight of administrative functions, Joy secures the stability of the enterprise, allowing the conglomerate to navigate complex market landscapes with agility and precision while fostering a culture of accountability and excellence throughout the entire corporate structure.

Isha Dube, the Ti Medical Chief of Staff at Murugappa, directs the operational integration of medical technology initiatives within the broader bio-product portfolio. Overseeing the coordination between research laboratories and commercialization teams, the Ti Medical Chief of Staff ensures that clinical advancements align with the strategic goals of the conglomerate. This leadership role involves managing the development pipeline for medical devices and health-related products. By streamlining the transition from prototype to market, Isha Dube directly impacts the growth of the medical division. Furthermore, the Ti Medical Chief of Staff facilitates collaboration with external regulatory bodies to ensure compliance and safety standards. Through the management of cross-functional project teams, Dube secures the successful deployment of innovative health solutions, positioning the organization as a leader in the medical technology space while driving significant value through scientific research and operational excellence.

Harsh Abbott, the Chief Medical Officer at Murugappa, directs the clinical strategy and scientific validation for the group's bio-product and medical technology ventures. Overseeing the rigorous testing protocols and health safety standards, the Chief Medical Officer ensures that all products meet the highest benchmarks of medical efficacy. This leadership role involves advising the board on emerging health trends and potential opportunities for innovation within the life sciences sector. By bridging the gap between clinical research and industrial application, Harsh Abbott directly impacts the quality and market relevance of the company's medical offerings. Furthermore, the Chief Medical Officer manages relationships with medical institutions and research partners to foster collaborative growth. Through the application of deep clinical expertise, Abbott secures the reputation of the organization as a trusted provider of advanced health solutions, driving long-term success through scientific integrity and patient-focused innovation.